Literature DB >> 1675271

Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system.

Y Kume1, F Maeda, H Harashima, H Kiwada.   

Abstract

Multilamellar vesicles (300-350 nm) were infused into the rat femoral vein at the rate of 4, 40 and 400 nmol phosphatidycholine min-1 for 6 h using [3H]inulin as an aqueous marker. The time courses of blood concentration of vesicles, normalized for infusion rate, were not superimposable, showing the non-linearity of liposome disposition in the blood circulation. These time courses of blood concentration were well fitted by a single Michaelis-Menten equation. On the other hand, the time courses of tissue content could not be so accommodated. Additionally, the observed relationship between the uptake of liposomes by the liver and their clearance from it and other organs differed essentially from a simulation based on Michaelis-Menten type saturable kinetics. Therefore, it is suggested that there is a time-dependent non-Michaelis-Menten type process in the phagocytosis of macrophages in the reticuloendothelial system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675271     DOI: 10.1111/j.2042-7158.1991.tb06658.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

Review 1.  Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems.

Authors:  Patrick M Glassman; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2019-03-05       Impact factor: 4.030

2.  Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

Authors:  H Harashima; K Sakata; H Kiwada
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

3.  Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition.

Authors:  Leonid Kagan; Pavel Gershkovich; Kishor M Wasan; Donald E Mager
Journal:  Pharm Res       Date:  2013-06-21       Impact factor: 4.200

4.  Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model.

Authors:  H Agashe; P Lagisetty; K Sahoo; D Bourne; B Grady; V Awasthi
Journal:  J Nanopart Res       Date:  2011-06-01       Impact factor: 2.253

5.  Liposomal methylprednisolone in rats: dose-proportionality and chronic-dose pharmacokinetics/pharmacodynamics.

Authors:  E V Mishina; W J Jusko
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

6.  Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.

Authors:  A Adedoyin; J F Bernardo; C E Swenson; L E Bolsack; G Horwith; S DeWit; E Kelly; J Klasterksy; J P Sculier; D DeValeriola; E Anaissie; G Lopez-Berestein; A Llanos-Cuentas; A Boyle; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

7.  Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation.

Authors:  E V Mishina; R M Straubinger; N A Pyszczynski; W J Jusko
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

8.  Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

Authors:  H Harashima; C Yamane; Y Kume; H Kiwada
Journal:  J Pharmacokinet Biopharm       Date:  1993-06

9.  Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.

Authors:  Y Sadzuka; S Hirotsu; S Hirota
Journal:  Jpn J Cancer Res       Date:  1999-02

10.  Flurbiprofen-loaded stealth liposomes: studies on the development, characterization, pharmacokinetics, and biodistribution.

Authors:  My Begum; K Abbulu; M Sudhakar
Journal:  J Young Pharm       Date:  2012-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.